维普中文期刊产品整合服务
16篇 您的检索式:作者名="Moore IF"
    题名 作者 年代 出处 被引量
1Measurement of lipid peroxidation 显示文摘K Moore L J Roberts If 1998Free Radic Res1998,28,6:1
2Alcohol consurnption and insulin resistance in young adults显示文摘FLANAGAN DE MOORE VM GODSLAND IF 2000Eur J Clin Invest2000,30,4:1
3Comparison of three principal component analysis techniques to porphyry copper alteration mapping: a case study in Meiduk area, Kerman, Iran 显示文摘Tangestani M H Moore IF 2001Canadian Journal of Remote Sensing2001,27,:1
4Gemcitabine: a promising new agent in the treatment of advanced urotheli- al cancer显示文摘Moore MJ Tannock IF Ernst DS 1997J Clin Oncol1997,15,12:1
5Safety of high-dose nicotinamide:a review显示文摘Knip M Douek IF Moore WP 2000Diabetologia2000,43,:1
6Fetal growth and the physiological control of glucose tolerance in adults: a minimal model analysis显示文摘Flanaqan DE Moore VM Godsland IF 2000American Journal of Physiology-Endocrinology and Metabolism2000,278,4:1
7Alcohol consumption and insulin resistance in young adults显示文摘Flanagan DE Moore VM Godsland IF 2000Eur J Clin Invest2000,30,:1
8TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics显示文摘Yang WR Moore IF Koteva KP 2004Journal of Biological Chemistry2004,279,52:1
9The role of systemic chemother- apy in the management of musele-invasive bladder cancer 显示文摘Juffs HG Moore MJ Tannoek IF 2002Lancet Oncol2002,3,12:1
10Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer显示文摘Moore MJ Osoba D Murphy K Tannock IF Armitage A Findlay B Coppin C Neville A Venner P Wilson J 1994Journal of Clinical Oncology1994,12,4:1
11Tigecycline is modified by the flavin-dependent monooxygenase TetX显示文摘Moore IF Hughes DW Wright GD 2005Biochemistry2005,44,11:1
12Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer 显示文摘Moore M J Tannock IF Scott Ernst D 1997J Clin Oncol1997,15,12:1
13Safety of high- dose nicotinamide: a review显示文摘Knip M Douek iF Moore WP 2000Diabetologia2000,43,11:1
14Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain显示文摘Ernst DS Tannock IF Winquist EW Venner PM Reyno L Moore MJ Chi K Ding K Elliott C Parulekar W 2003Journal of Clinical Oncology2003,21,17:1
15Tigecycline is modified bythe flavin - dependent monooxygenase TetX 显示文摘Moore IF Hughes DW Wright GD 2005Biochemistry2005,44,11:1
16Gemcitabine: a promising new agent in the treatment advanced urothelial cancer 显示文摘Moore MJ Tannock IF Ernst DS 1997J Clin Oncol1997,15,12:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费